Search

Search Constraints

You searched for: Author/Creator Nicolau, Claude

Search Results

1. Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial. Issue 1 (December 2016)

2. Hypoxia‐driven Hif2a coordinates mouse liver regeneration by coupling parenchymal growth to vascular expansion. Issue 6 (7th October 2016)

3. Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia—Myo-inositoltrispyrophophate as model. (April 2020)

4. Myo‐inositol trispyrophosphate‐mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy. Issue 11 (25th November 2013)

6. The Allosteric Hemoglobin Effector ITPP Inhibits Metastatic Colon Cancer in Mice. Issue 5 (November 2017)